GLP-1 Drugs Linked to Lower Breast-Cancer Risk in 2026 ASCO Data
New data presented at the 2026 ASCO annual meeting add breast cancer to the growing list of conditions GLP-1 medicines such as semaglutide may help protect against.
News, tech and practical guides
